Company
Universe Pharmaceuticals INC (UPC)
Standardized SEC financial data for Universe Pharmaceuticals INC — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001809616 · NASDAQ · Pharmaceutical Preparations.
Gross margin
35.3%
Operating margin
-16.3%
Net margin
-20.6%
Revenue growth (YoY)
-22.4%
Return on equity
-6.5%
ROIC
-9.3%
Free cash flow
-$5.32B
Debt / equity
0.04×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $30.7M | $48.0M | $40.1M | $32.31B | $23.02B | $17.86B |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.1M | $8.1M | $5.71B | $5.29B | $29.50B | $33.59B |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $6.1M | -$2.1M | -$1.3M | $1.12B | -$9.51B | -$5.05B |
| Capital expenditures |
Get UPC data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/UPC/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/UPC/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"